/Investor DB

Obvious Ventures — 2017 Investments

6 investments dated 2017 · listed companies and verified rows first · show all

Recursion Pharmaceuticalsrecursion.comin𝕏NASDAQ: RXRXSep 2017 · $60M

Recursion applies computational and data-driven approaches to biological science, aiming to accelerate drug discovery and develop new treatments.

AI & Machine LearningBiotechData & InfrastructureDeep TechMedical DevicesSalt Lake City, US

Chris Gibson(Co-founder and Chairman of the Board)inBlake C. Borgeson(Executive Officer, Director)inDean Y. Yi(Executive Officer, Director)Najat Khan(Chief Executive Officer)inNajat Khan, Ph.D.(CEO and President)inBlake Borgeson(Founder)

Co-investorsDCVC (Data Collective)Lux CapitalBaillie GiffordAdvantage Capital PartnersAir Street CapitalAmplify Partners+22 more

Pegasus Solarpegasussolar.cominSep 2017SEC filingmedium confidence

Pegasus Solar designs and manufactures rooftop solar mounting systems and installation hardware for solar installers.

CleantechConstruction TechEnergyHardwareSaaSSan Jose, US

Kai Stephan(Founder)inErich Kai Stephan(Executive Officer, Director)

BoardMark Conroy(Director)B. Marc Averitt(Director)in

Board seatMike Miskovsky· per SEC Form D · $8.6M raise · filed Sep 2017

Co-investorsC3 VenturesEcosystem Integrity FundBand of AngelsEcosystem IntegrityOkapi Venture Capital

Devoted Healthdevoted.comOct 2017

Devoted Health offers Medicare Advantage plans and integrated healthcare services for older Americans, including virtual and in-home care, member support guides, and coordination with local providers across 29 states.

HealthtechInsurTechUnited States, US

Todd Park(Founder)inEd Park(Founder)in

BoardBryan Roberts(Director)inRobert Kocher(Director)inWilliam Frist(Director)inKathleen Sebelius(Director)

PartnerVishal Vasishth· led

Co-investorsAndreessen HorowitzBronze InvestmentsCapital FactoryCox EnterprisesDns CapitalDreamers VC+31 more

Highlyhighly.coSeed · Jul 2017

Co-investorsAlumni VenturesBloomberg Beta

LabGeniuslabgeni.usin𝕏Oct 2017

LabGenius develops EVA, an automated discovery engine for identifying and co-optimizing complex therapeutic antibodies such as multispecifics across multiple properties.

AI & Machine LearningBiotechDeep TechLondon

Harrison Rickerby(Executive Officer, Director)

BoardJames Field(Founder)in

Co-investorsAcequia Capital (AceCap)Air Street CapitalAtomicoBackedBeast VenturesChampion Hill Ventures+9 more

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Bonvee

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.